The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: A meta-analysis

European Journal of Emergency Medicine

Volumn 18, Issue 3, 2011, Pages 148-152

  Delaney, Ben ^a   Loy, John ^a   Kelly, Anne Maree ^a  

^a SUNSHINE HOSPITAL   (Australia)

Author keywords

adenosine; meta analysis; supraventricular tachycardia; verapamil

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; DILTIAZEM; VERAPAMIL;

ARTICLE; DRUG DOSE INCREASE; DRUG EFFICACY; HUMAN; HYPOTENSION; MEDICAL LITERATURE; META ANALYSIS; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINUS RHYTHM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADENOSINE; ADULT; ANTI-ARRHYTHMIA AGENTS; CONFIDENCE INTERVALS; HUMANS; TACHYCARDIA, SUPRAVENTRICULAR; VERAPAMIL;

EID: 79955812159     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e3283400ba2     Document Type: Article

References (17)

1. Bolton E. Disturbances of cardiac rhythm and conduction. In: Tintinalli J, editor. Emergency medicine: a comprehensive study guide. 6th ed. New York (NY): McGraw-NHill; 2004., p179-p202.
2. American Heart Association. 2005 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7.3: management of symptomatic bradycardia and tachycardia. Circulation 2005; 112:IV67-IV77.
3. Innes JA. Review article: adenosine use in the emergency department. Emerg Med Australas 2008; 20:209-215. (Pubitemid 351792878)
4. American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 1992; 268:2212-2302.
5. American Heart Association. Guidelines for cardiopulmonary resuscitation emergency cardiac care. Part 6: advanced cardiovascular life support. section 5: pharmacology I: agents for arrhythmias. Circulation 2000; 102:I112-I128.
6. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DG, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12. (Pubitemid 26120810)
7. Cabrera-Sole R, Abeytua M, Lopez L, Rubio R. Supraventricular paroxystic tachycardia: effectiveness of adenosine versus verapamil. Rev Esp Cardiol 1989; 42(Suppl 2):19. (Pubitemid 19279613)
8. Cheng KA. A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia. Zhonghua Nei Ke Za Zhi 2003; 42:773-776. (Chinese Journal of Internal Medicine)
9. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med 1990; 113:104-110.
10. Ferreira JFM, Pamplona D, Cesar LAM, Leite PF, Sosa EA, Da Luz PL, et al. Adenosin-three phosphate compared with verapamil to treat paroxysmal supraventricular tachycardia. Arq Bras Cardiol 1996; 66:55-57. (Pubitemid 26092215)
11. Gil Madre J, Lazaro Rodriguez S, Sentenac Merchan G, Sepulveda Berrocal MA, Alises Moraleda JM, Cortes Bermejo S, et al. Adenosine triphosphate in the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil. Rev Esp Cardiol 1995; 48:55-58.
12. Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 2009; 80:523-528.
13. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. Am Heart J 1992; 123:1543-1549.
14. Kulakowski P, Karpinski G, Karczmarewicz S, Czepiel A, Makowska E, Soszynska M. Efficacy and safety of adenosine in termination of paroxysmal supraventricular tachycardia: comparison with verapamil. Kardiol Pol 1998; 49:295-303. (Pubitemid 28513316)
15. Faulds D, Chrisp P, Buckley MM. Adenosine: an evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 1991; 41:596-624. (Pubitemid 21920744)
16. Holdgate A, Foo A. Adenosine versus calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database Syst Rev 2006. [Issue 4. Art. No.: CD005154. doi: 10.1002/14651858.CD005154.pub2]
17. Greco R, Musto B, Arienzo V, Alborino A, Garofalo S, Marsico F. Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate and verapamil: a comparative study. Circulation 1982; 66:504-508. (Pubitemid 12038569)